Monday, May 23, 2022
  • About
  • Advertise
  • Careers
  • Contact
Star Today Logo
  • Home
  • News
  • Business
  • Politics
  • Investigation
  • Health
  • Opinion
No Result
View All Result
Star Today Logo
Home Health

Coronavirus: Oxford University vaccine trial paused after participant falls ill

by Star Today
September 9, 2020
in Health, News
2 min read
Coronavirus: Oxford University vaccine trial paused after participant falls ill
43
SHARES
2.3k
VIEWS
Share on FacebookShare on TwitterShare on Whatsapp

Final clinical trials for a coronavirus vaccine, developed by AstraZeneca and Oxford University, have been put on hold after a participant had a suspected adverse reaction in the UK.

AstraZeneca described it as a “routine” pause in the case of “an unexplained illness”.

Readers' Choice

Asanyo wants Angwenyi apologize over remark

Asanyo wants Angwenyi apologize over remark

May 23, 2022
Uganda Tourism Board in Roadshow to boost cross boarder Tourism between Kenya and Uganda

Uganda Tourism Board in Roadshow to boost cross boarder Tourism between Kenya and Uganda

May 23, 2022

The outcome of vaccine trials is being closely watched around the world.

The AstraZeneca-Oxford University vaccine is seen as a strong contender among dozens being developed globally.

Hopes have been high that the vaccine might be one of the first to come on the market, following successful phase 1 and 2 testing.

Its move to Phase 3 testing in recent weeks has involved some 30,000 participants in the US as well as in the UK, Brazil and South Africa. Phase 3 trials in vaccines often involve thousands of participants and can last several years.

The New York Times is reporting a volunteer in the UK trial has been diagnosed with transverse myelitis, an inflammatory syndrome that affects the spinal cord and can be caused by viral infections.

However, the cause of the illness has not been confirmed and an independent investigation will now work out if there was any link to the vaccine.

At first glance this may seem alarming. A vaccine trial – and not just any vaccine, but one receiving massive global attention – is put on hold due to a suspected serious adverse reaction. But such events are not unheard of.

Indeed the Oxford team describe it as “routine”. Any time a volunteer is admitted to hospital and the cause of their illness is not immediately apparent it triggers a study to be put on hold.

This is actually the second time it has happened with the Oxford University/AstraZeneca coronavirus vaccine trial since the first volunteers were immunised in April. An Oxford University spokesperson said: “In large trials, illnesses will happen by chance but must be independently reviewed to check this carefully.”

A final decision on restarting the trial will be taken by the medical regulator the MHRA, which could take only days. But until then all international vaccination sites, in the UK, Brazil, South Africa and the USA are on hold.

The Oxford University team believe this process illustrates that they are committed to the safety of their volunteers and the highest standards of conduct in their studies.

Tags: Coronavirusoxford university
ShareTweetSend
Previous Post

Co-op Bank signs Sh500m fertilizer deal with Yara East Africa

Next Post

Governor Korane at EACC over Sh233m grant fund probe

Related Posts

Asanyo wants Angwenyi apologize over remark
News

Asanyo wants Angwenyi apologize over remark

May 23, 2022
Uganda Tourism Board in Roadshow to boost cross boarder Tourism between Kenya and Uganda
Business

Uganda Tourism Board in Roadshow to boost cross boarder Tourism between Kenya and Uganda

May 23, 2022
Co-op Bank, IFC partner in health equipment funding
Business

Saccos to share Sh3.8b Co-op Bank dividend cheque

May 23, 2022
Next Post
Governor Korane at EACC over Sh233m grant fund probe

Governor Korane at EACC over Sh233m grant fund probe

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

ADVERTISEMENT

NEWS BRIEFS

Asanyo wants Angwenyi apologize over remark

Asanyo wants Angwenyi apologize over remark

May 23, 2022
Uganda Tourism Board in Roadshow to boost cross boarder Tourism between Kenya and Uganda

Uganda Tourism Board in Roadshow to boost cross boarder Tourism between Kenya and Uganda

May 23, 2022
Co-op Bank, IFC partner in health equipment funding

Saccos to share Sh3.8b Co-op Bank dividend cheque

May 23, 2022
Co-op customers borrow Sh164m daily in digital salary advances

Co-op Bank injects Ksh372 million into South Sudan unit

May 23, 2022
Inside Co-operative Bank’s internet banking

Co-operative Bank offers best solutions for back to school

April 26, 2022

About Star Today

Star Today gives you the latest news stories written by local journalists for the ordinary Kenyan.

Recent News

  • Asanyo wants Angwenyi apologize over remark
  • Uganda Tourism Board in Roadshow to boost cross boarder Tourism between Kenya and Uganda
  • Saccos to share Sh3.8b Co-op Bank dividend cheque

Category

  • Business
  • Health
  • Investigation
  • News
  • Opinion
  • Politics

Recent News

Asanyo wants Angwenyi apologize over remark

Asanyo wants Angwenyi apologize over remark

May 23, 2022
Uganda Tourism Board in Roadshow to boost cross boarder Tourism between Kenya and Uganda

Uganda Tourism Board in Roadshow to boost cross boarder Tourism between Kenya and Uganda

May 23, 2022
  • About
  • Advertise
  • Careers
  • Contact

© 2020 | Star Today

No Result
View All Result
  • Home
  • News
  • Business
  • Politics
  • Investigation
  • Health
  • Opinion

© 2020 | Star Today